PROGNOSIS OF MUCINOUS HISTOLOGY FOR PATIENTS WITH RADICALLY RESECTED STAGE II AND III COLON CANCER

被引：0

作者：

Catalano, V ^{[1
]}

Loupakis, F. ^{[2
]}

Graziano, F. ^{[1
]}

Bisonni, R. ^{[3
]}

Torresi, U. ^{[4
]}

Vincenzi, B. ^{[5
]}

Mari, D. ^{[6
]}

Giordani, P. ^{[1
]}

Baldi, G. ^{[2
]}

Santini, D.

Giustini, L. ^{[3
]}

Silva, R. R. ^{[6
]}

Falcone, A. ^{[2
]}

D'Emidio, S. ^{[1
]}

Rocchi, M. ^{[7
]}

Fedeli, Luzi S. ^{[1
]}

机构：

[1] AO Osped San Salvatore, Pesaro, Italy

[2] Univ Pisana, Oncol Univ 2, Azienda Osped, Pisa, Italy

[3] Osped Fermo, Rome, Italy

[4] Osped Macerata, Rome, Italy

[5] Univ Campus BioMed, Rome, Italy

[6] Osped Fabriano, Fabriano, Italy

[7] Univ Urbino, Ist Biomatemat, I-61029 Urbino, Italy

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[21] FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
Sharif, Saima
O'Connell, Michael J.
Yothers, Greg
Lopa, Samia
Wolmark, Norman
CANCER INVESTIGATION, 2008, 26 (09) : 956 - 963
[22] Adjuvant chemoradiation in stage III-IV radically resected gastric cancer patients: a pilot study
Orditura, M.
Martinelli, E.
De Vita, F.
Galizia, G.
Muto, P.
Vitiello, F.
Romano, A.
Troiani, T.
Morgillo, F.
Ciardiello, F.
EJC SUPPLEMENTS, 2009, 7 (02): : 376 - 376
[23] An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer
Urrejola, Gonzalo I.
Bambs, Claudia E.
Espinoza, Manuel A.
Gellona, Jose
Zuniga, Alvaro M.
Elena Molina, Maria
Bellolio, Felipe
Miguieles, Rodrigo
Campbell, James M.
Pinedo, George A.
REVISTA MEDICA DE CHILE, 2013, 141 (05) : 602 - 608
[24] Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patients -: Toxicity and prognosis
Jensen, Soren Astrup
Vilmar, Adam
Sorensen, Jens Benn
MEDICAL ONCOLOGY, 2006, 23 (04) : 521 - 531
[25] The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
Pantano, Francesco
Berti, Pierpaolo
Guida, Francesco Maria
Perrone, Giuseppe
Vincenzi, Bruno
Amato, Michelina Maria Carla
Righi, Daniela
Dell'Aquila, Emanuela
Graziano, Francesco
Catalano, Vincenzo
Caricato, Marco
Rizzo, Sergio
Muda, Andrea Onetti
Russo, Antonio
Tonini, Giuseppe
Santini, Daniele
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (11) : 1415 - 1421
[26] Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patientsToxicity and prognosis
Søren Astrup Jensen
Adam Vilmar
Jens Benn Sørensen
Medical Oncology, 2006, 23 : 521 - 531
[27] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
Moretto, Roberto
Falcone, Alfredo
Cremolini, Chiara
INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
[28] Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer
Abrams, Thomas A.
Brightly, Rick
Mao, Jianbin
Kirkner, Gregory
Meyerhardt, Jeffrey A.
Schrag, Deborah
Fuchs, Charles S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3255 - 3262
[29] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
Sobrero, A
Frassineti, G
Falcone, A
Dogliotti, L
Rosso, R
Costanzo, FD
Bruzzi, P
BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 24 - 29
[30] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
A Sobrero
G Frassineti
A Falcone
L Dogliotti
R Rosso
F D Costanzo
P Bruzzi
British Journal of Cancer, 2005, 92 : 24 - 29

← 1 2 3 4 5 →